Study of AZD0754 in Participants with Metastatic Prostate Cancer

Trial Identifier: D9660C00001
Sponsor: AstraZeneca
Start Date: March 2024
Primary Completion Date: November 2026
Study Completion Date: November 2026
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU East Melbourne, AU, 3002
ES Pamplona, ES, 31008
US, CA Duarte, CA, US, 91010
US, FL Tampa, FL, US, 33612
US, GA Atlanta, GA, US, 30322
US, KS Westwood, KS, US, 66205
US, MA Boston, MA, US, 02215
US, MA Boston, MA, US, 02114
US, MO Saint Louis, MO, US, 63110
US, NJ Hackensack, NJ, US, 07601
US, NY New York, NY, US, 10065
US, NY New York, NY, US, 10032
US, PA Philadelphia, PA, US, 19104
US, TX Dallas, TX, US, 75235
US, TX Houston, TX, US, 77030